Publikationen von W. Machleidt

Pfizer, J. M.; Assfalg-Machleidt, I.; Machleidt, W.; Moroder, L.; Schaschke, N.: Primed-site probing of papain-like cysteine proteases. INTERNATIONAL JOURNAL OF PEPTIDE RESEARCH AND THERAPEUTICS 13 (1-2), S. 93 - 104 (2007)

FIORINO, F.; GIL-PARRADO, S.; ASSFALG-MACHLEIDT, I.; MACHLEIDT, W.; MORODER, L.: A new cell-permeable calpain inhibitor. Journal of Peptide Science 13, S. 70 - 73 (2007)

Pfizer, J. M.; Assfalg-Machleidt, I.; Machleidt, W.; Moroder, L.; Schaschke, N.: Primed-site Probing of Papain-like Cysteine Proteases. Int. J. Peptide Res. & Therapeut. 13 (1-2), S. 93 - 104 (2007)

Joy, J.; Nalabothula, N.; Ghosh, M.; Popp, O.; Jochum, M.; Machleidt, W.; Gil-Parrado, S.; Holak, T. A.: Identification of calpain cleavage sites in the G1 cyclin-dependent kinase inhibitor p19(INK4d). Biological Chemistry 387 (3), S. 329 - 335 (2006)

Ghosh, M.; Shanker, S.; Siwanowicz, I.; Mann, K.; Machleidt, W.; Holak, T. A.: Proteolysis of insulin-like growth factor binding proteins (IGFBPs) by calpain. Biological Chemistry 386, S. 85 - 93 (2005)

Buth, H.; Wolters, B.; Hartwig, B.; Meier-Bornheim, R.; Veith, H.; Hansen, M.; Sommerhoff, C. P.; Schaschke, N.; Machleidt, W.; Fusenig, N. E. et al.; Boukamp, P.; Brix, K.: HaCaT keratinocytes secrete lysosomal cysteine proteinases during migration. European Journal of Cell Biology 83 (11), S. 781 - 795 (2004)

Kaiser, M.; Milbradt, A. G.; Siciliano, C.; Assfalg-Machleidt, I.; Machleidt, W.; Groll, M.; Renner, C.; Moroder, L.: TMC-95A analogues with endocyclic biphenyl ether group as proteasome inhibitors. Chemistry & Biodiversity 1 (1), S. 161 - 173 (2004)

Gil-Parrado, S.; Popp, O.; Knoch, T. A.; Zahler, S.; Bestvater, F.; Felgentrager, M.; Holloschi, A.; Fernandez-Montalvan, A.; Auerswald, E. A.; Fritz, H. et al.; Fuentes-Prior, P.; Machleidt, W.; Spiess, E.: Subcellular localization and in vivo subunit interactions of ubiquitous μ-calpain. Journal of Biological Chemistry 278 (18), S. 16336 - 16346 (2003)

Gil-Parrado, S.; Assfalg-Machleidt, I.; Fiorino, F.; Deluca, D.; Pfeiler, D.; Schaschke, N.; Moroder, L.; Machleidt, W.: Calpastatin exon 1B-derived peptide, a selective inhibitor of calpain: Enhancing cell permeability by conjugation with penetratin. Biological Chemistry 384 (3), S. 395 - 402 (2003)

Balaji, K. N.; Schaschke, N.; Machleidt, W.; Catalfamo, M.; Henkart, P. A.: Surface cathepsin B protects cytotoxic lymphocytes from self- destruction after degranulation. Journal of Experimental Medicine 196 (4), S. 493 - 503 (2002)

Gil-Parrado, S.; Fernandez-Montalvan, A.; Assfalg-Machleidt, I.; Popp, O.; Bestvater, F.; Holloschi, A.; Knoch, T. A.; Auerswald, E. A.; Welsh, K.; Reed, J. C. et al.; Fritz, H.; Fuentes-Prior, P.; Spiess, E.; Salvesen, G. S.; Machleidt, W.: Lonomycin-activated calpain triggers apoptosis - A probable role for Bcl-2 family members. Journal of Biological Chemistry 277 (30), S. 27217 - 27226 (2002)

Schaschke, N.; Deluca, D.; Assfalg-Machleidt, I.; Höhneke, C.; Sommerhoff, C. P.; Machleidt, W.: Epoxysuccinyl peptide-derived cathepsin B inhibitors: Modulating membrane permeability by conjugation with the C- terminal heptapeptide segment of penetratin. Biological Chemistry 383 (5), S. 849 - 852 (2002)

Pfizer, J. M.; Assfalg-Machleidt, I.; Machleidt, W.; Moroder, L.; Schaschke, N.: Primed-site probing of papain-like cysteine proteases. In: Peptides 2004, S. 668 - 669 (Hg. Flegel, M.; Fridkin, M.; Gilon, C.; Slaninova, J.). Kenes International, Geneva/Switzerland (2005)